In many countries, screening for colorectal cancer (CRC) relies on repeat testing using the guaiac faecal occult blood test (gFOBT). This study aimed to compare gFOBT performance measures between ...
We investigated variations in sensitivity of an immunochemical (I-FOBT) and a guaiac (G-FOBT) faecal occult blood test according to type and location of lesions in an average-risk 50- to 74-year-old ...
In an English cohort study, patients with symptomatic presentation of colorectal cancer (CRC) and faecal immunochemical test (FIT) results ≥ 10 µg of haemoglobin (Hb)/g had a higher risk for 1-year ...
In England, 37 people die each day from bowel cancer, but screening using faecal blood testing followed by a colonoscopy can reduce both the incidence of this cancer and the number of resulting deaths ...
A simple home faecal immunochemical test that detects small amounts of blood in poo is sparing thousands of people from unnecessary hospital investigations for bowel cancer, while helping them get fas ...
Colorectal cancer may be associated with a variety of symptoms, including blood in faeces. Small amounts of hidden blood in faeces (known as faecal occult blood) can show that there is bleeding from ...
In England, 37 people die each day from bowel cancer, but screening using faecal blood testing followed by colonoscopy can reduce both the incidence of this cancer and the number of resulting deaths.
The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...
John Crouchley lost about 5st (32kg) after experiencing digestive problems, before his diagnosis.
Australia’s recent move to lower the starting age for bowel (colorectal) cancer screening from 50 down to 45 years old will mean better outcomes – but it will also increase the burden on an already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results